A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
A corn puff recall has been expanded to include two more products over concerns the snacks could cause “serious or life-threatening” allergic reactions, federal officials said. The recall of Shirakiku ...
Results that may be inaccessible to you are currently showing.